(Press-News.org) For persons with cardiovascular disease or diabetes, urinary sodium excretion (a surrogate for salt intake) at higher levels or at lower levels compared to mid-range values was associated with an increased risk of cardiovascular events (for higher levels) or cardiovascular death and hospitalization for congestive heart failure (for lower levels), according to a study in the November 23/30 issue of JAMA. Also, higher estimated urinary potassium excretion was associated with a reduced risk of stroke.
There is uncertainty regarding the optimal daily intake of sodium. Findings from prospective cohort studies, evaluating the association between sodium intake and cardiovascular (CV) events, have been conflicting. "Clarifying the optimal daily intake of sodium is particularly important in patients with established CV disease, where it has been inadequately studied. Patients with CV disease may be especially vulnerable to the CV effects of high and low sodium intake and are most likely to receive recommendations on restricting sodium intake," according to background information in the article. The authors add that the optimal level of daily potassium intake, a proposed modifier of the association between sodium intake and CV disease, has not been established.
Martin J. O'Donnell, M.B., Ph.D., and Salim Yusuf, D.Phil., F.R.C.P.C., F.R.S.C., of McMaster University, Hamilton, Ontario, Canada, and colleagues examined the association between sodium and potassium excretion (markers of intake) and CV events and mortality. The study consisted of an observational analyses of 2 cohorts (n = 28,880) included in the ONTARGET and TRANSCEND trials (November 2001-March 2008 from initial recruitment to final follow-up). The researchers estimated 24-hour urinary sodium and potassium excretion from a morning fasting urine sample. Multivariable models were used to determine the association of urinary sodium and potassium with CV events (myocardial infarction [MI; heart attack], stroke, and hospitalization for congestive heart failure (CHF) and mortality.
At study entry, the average estimated 24-hour excretion for sodium was 4.77 g and 2.19 g for potassium. After a median (midpoint) follow-up of 56 months, the composite outcome occurred in 4,729 (16.4 percent) participants. The researchers found that after multivariable analysis, compared with baseline sodium excretion of 4 to 5.99 g per day (n = 14,156 [15.2 percent with the composite outcome]), higher baseline sodium excretion (18.4 percent for 7-8 g/d and 24.1 percent for greater than 8 g/d) and lower sodium excretion (18.2 percent for 2-2.99 g/d and 20.2 percent for less than 2g/d) were associated with an increased risk of the composite of CV death, heart attack, stroke, and hospitalization for CHF.
Compared with the reference group, higher baseline sodium excretion was associated with an increased risk of CV death (9.7 percent for 7-8 g/day; and 11.2 percent for greater than 8 g/day), MI (6.8 percent for greater than 8 g/day), stroke (6.6 percent for greater than 8 g/day), and hospitalization for CHF (6.5 percent for greater than 8 g/day). Lower sodium excretion was associated with an increased risk of CV death (8.6 percent for 2-2.99 g/day; 10.6 percent for less than 2 g/day), and hospitalization for CHF (5.2 percent for 2-2.99 g/day) on multivariable analysis. Compared with an estimated potassium excretion of less than 1.5 g per day, higher potassium excretion was associated with a reduced risk of stroke on multivariable analysis.
The researchers note that previous individual prospective cohort studies have either reported a positive association, no association, or an inverse relationship between sodium intake and CV mortality. "Discrepant findings of previous studies are likely due to differences in ranges of sodium intake, study populations, methods of measurement, and failure to explore a nonlinear association."
"Compared with moderate sodium excretion, we found an association between high sodium excretion and CV events and low sodium excretion and CV death and hospitalization for CHF, which emphasizes the urgent need to establish a safe range for sodium intake in randomized controlled trials. Higher urinary potassium excretion was associated with lower stroke risk and is a potential intervention that merits further evaluation for stroke prevention."
(JAMA. 2011;306[20]:2229-2238. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Urinary Sodium and Cardiovascular Disease Risk
In an accompanying editorial, Paul K. Whelton, M.B., M.D., M.Sc., of the Tulane University School of Public Health and Tropical Medicine, New Orleans, comments on the importance of reducing salt intake.
"Most U.S. adults consume levels of sodium far in excess of physiologic need, and the vast majority of that excess is added during the processing of foods. A progressive reduction in the addition of sodium to food products could represent one of the 'lifestyle' changes with the greatest potential for intervention success. This shift to a more natural diet would concurrently lead to an absolute increase in dietary potassium content and also lead to an improved sodium-potassium ratio, which may be more desirable than change of either electrolyte on its own. The scientific underpinning for the health benefits from sodium reduction is strong, and the available evidence does not support deviating from the stated goal of reducing the exposure to dietary sodium in the general population."
(JAMA. 2011;306[20]:2262-2264. Available pre-embargo to the media at http://www.jamamedia.org)
###
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
To contact Martin J. O'Donnell, M.B., Ph.D., call Veronica McGuire at 905-525-9140, ext. 22169; or email vmcguir@mcmaster.ca. To contact editorial author Paul K. Whelton, M.B., M.D., M.Sc., email Arthur Nead at anead@tulane.edu.
Study assesses association between urinary salt excretion and risk of cardiovascular events or death
2011-11-23
ELSE PRESS RELEASES FROM THIS DATE:
Among patients with infective endocarditis and heart failure, valvular surgery may reduce mortality
2011-11-23
CHICAGO – Among patients with infective endocarditis (an infection of the heart lining which may involve the heart valves) and heart failure, about two-thirds undergo valvular surgery, which is associated with a significant reduction in the risk of death in the hospital and at one year, according to a study in the November 23/30 issue of JAMA.
"Infective endocarditis is associated with substantial morbidity and mortality. Several published studies have reported in-hospital mortality of 15 percent to 20 percent and l-year mortality of 40 percent. In the United States ...
Paracetamol: Repeated ingestion of slightly too much can be fatal -- recognize and treat quickly
2011-11-23
Repeatedly taking slightly too much paracetamol over time can cause a dangerous overdose that is difficult to spot, but puts the person at danger of dying. Patients may not come to hospital reporting the overdose, but because they feel unwell. This clinical situation needs to be recognized and treated rapidly because these patients are at even greater danger than people who take single overdoses.
These so-called staggered overdoses can occur when people have pain and repeatedly take a little more paracetamol than they should. "They haven't taken the sort of single-moment, ...
P Rex-1 protein key to melanoma metastasis
2011-11-23
Chapel Hill, NC – Researchers from UNC Lineberger Comprehensive Cancer Center are part of a team that has identified a protein, called P-Rex1, that is key to the movement of cells called melanoblasts. When these cells experience uncontrolled growth, melanoma develops.
Melanoma is one of the only forms of cancer that is still on the rise and is one of the most common forms of cancer in young adults. The incidence of melanoma in women under age 30 has increased more than 50 percent since 1980. Metastases are the major cause of death from melanoma.
The team found that ...
Earlier antiretroviral therapy might reduce the burden of cancer in those with HIV
2011-11-23
OAKLAND, Calif., November 22, 2011 – HIV-infected patients are at increased risk for cancer as a result of both their impaired immune system and lifestyle factors, such as smoking, according to researchers at Kaiser Permanente.
The study, which appears in the current issue of Cancer Epidemiology, Biomarkers and Prevention, is among the first to directly compare the risk of cancer in HIV-infected patients with a comparison group without HIV infection, while accounting for major cancer risk factors.
Of the 10 cancer types studied, six were more common in HIV patients, ...
Consuming canned soup linked to greatly elevated levels of the chemical BPA
2011-11-23
A new study from researchers at the Harvard School of Public Health (HSPH) has found that a group of volunteers who consumed a serving of canned soup each day for five days had a more than 1,000% increase in urinary bisphenol A (BPA) concentrations compared with when the same individuals consumed fresh soup daily for five days. The study is one of the first to quantify BPA levels in humans after ingestion of canned foods.
The findings were published online November 22, 2011, in the Journal of the Medical Association (JAMA) and will appear in the November 23/30 print issue.
"Previous ...
BUSM researchers identify molecular mechanism that regulates wakefulness, sleep
2011-11-23
(Boston) – Researchers at Boston University School of Medicine (BUSM) have, for the first time, identified an intracellular signaling enzyme that regulates the wake-sleep cycle, which could help lead to the development of more effective sleep aid medications. Subimal Datta, PhD, director and principle investigator at the Laboratory of Sleep and Cognitive Neuroscience at BUSM, led the study, which points to a specific enzyme inside neurons in the brain that trigger an important shift in consciousness from sleep to wakefulness and wakefulness to sleep.
The results will ...
Psychopaths' brains show differences in structure and function
2011-11-23
Madison, Wis. — Images of prisoners' brains show important differences between those who are diagnosed as psychopaths and those who aren't, according to a new study led by University of Wisconsin-Madison researchers.
The results could help explain the callous and impulsive anti-social behavior exhibited by some psychopaths.
The study showed that psychopaths have reduced connections between the ventromedial prefrontal cortex (vmPFC), the part of the brain responsible for sentiments such as empathy and guilt, and the amygdala, which mediates fear and anxiety. Two types ...
McMaster study calls sodium intake guidelines into question
2011-11-23
Hamilton, ON (Nov. 22, 2011) – For years doctors have warned that too much salt is bad for your heart. Now a new McMaster University study suggests that both high and low levels of salt intake may put people with heart disease or diabetes at increased risk of cardiovascular complications.
The study, published in the Journal of the American Medical Association (JAMA) today, found that moderate salt intake was associated with the lowest risk of cardiovascular events, while a higher intake of sodium was associated with an increased risk of stroke, heart attack and other ...
Researchers draft blueprint to boost energy innovation
2011-11-23
CAMBRIDGE, Mass. – The U.S. government could save the economy hundreds of billions of dollars per year by 2050 by spending a few billion dollars more a year to spur innovations in energy technology, according to a new report by researchers at the Harvard Kennedy School.
Achieving major cuts in carbon emissions in the process will also require policies that put a substantial price on carbon or set clean energy standards, the researchers find.
The report is the result of a three-year project to develop a set of actionable recommendations to achieve "a revolution in energy ...
UT Southwestern team identifies tumor-specific pathway
2011-11-23
DALLAS -- A research team led by UT Southwestern Medical Center scientists has identified an atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer.
Dr. Ralph DeBerardinis, senior author of the study published Nov. 20 in Nature, likened the newly discovered pathway to traffic that is rerouted during a highway construction project.
"If we hone in on this reverse pathway, then we may be able to prevent the growth of certain types of cancer," said Dr. DeBerardinis, assistant professor ...